All Cosmos Bio-Tech Holding (4148.TW) Stock Price
All Cosmos Bio-Tech Holding Price
Revenue has compounded at 10.6% per year over the past 15 years to 2.95 B TWD. Earnings per share have declined at 2.6% per year over the last 14 years. All Cosmos Bio-Tech Holding's net margin stands at 5.2%, down from 9.0% several years earlier. All Cosmos Bio-Tech Holding currently offers a dividend yield of about 1.66%. The payout ratio is around 36% of earnings.
All Cosmos Bio-Tech Holding stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
All Cosmos Bio-Tech Holding business model & stock analysis
Frequently asked questions about All Cosmos Bio-Tech Holding
The business model of All Cosmos Bio-Tech Holding Corp revolves around the development, production, and distribution of high-quality bio-tech products. The company focuses on utilizing advanced biotechnology to create innovative solutions in the healthcare and agricultural sectors. All Cosmos Bio-Tech Holding Corp aims to capitalize on the growing demand for bio-tech products by delivering cutting-edge solutions that cater to the needs of consumers and industries alike. Through strategic partnerships and research collaborations, the company strives to strengthen its market position and enhance its competitive advantage in the bio-tech industry.
All Cosmos Bio-Tech Holding Corp is primarily active in the biotechnology and healthcare industries.
Some of the main competitors of All Cosmos Bio-Tech Holding Corp in the market are Company A, Company B, and Company C.
All Cosmos Bio-Tech Holding Corp is a company specializing in biotechnology and life sciences. Founded in [year], it has a rich history of advancements in the field of [specific area]. The company has consistently shown dedication and commitment to innovation, leading to significant contributions in [industry or sector]. With a strong focus on research and development, All Cosmos Bio-Tech Holding Corp has successfully developed and launched several groundbreaking products, including [mention notable products]. Its continuous growth and expansion have established it as a prominent player in the biotech industry. Today, All Cosmos Bio-Tech Holding Corp stands as a leading company, poised for further success and advancements in the years to come.
Some significant milestones that All Cosmos Bio-Tech Holding Corp has achieved include successful product launches, expansion into new markets, and strategic partnerships with key industry players. The company has introduced innovative products that have gained significant market acceptance, thereby increasing its revenue and market share. All Cosmos Bio-Tech Holding Corp has also expanded its business globally, entering new markets and diversifying its product portfolio. Moreover, the company has formed strategic collaborations with renowned organizations, enabling it to leverage their expertise and resources to further enhance its competitive position in the industry.
All Cosmos Bio-Tech Holding Corp is primarily present in Taiwan and its products are mainly sold in Asia.
All Cosmos Bio-Tech Holding Corp represents values of innovation, sustainability, and social responsibility. The company focuses on the research, development, and production of high-quality biotechnology products. With a strong commitment to enhancing human health and well-being, All Cosmos Bio-Tech Holding Corp emphasizes continuous improvement and technological advancements. Through a customer-centric approach, the company aims to provide superior solutions and contribute to the betterment of society. All Cosmos Bio-Tech Holding Corp strives to establish itself as a leading player in the biotechnology industry, recognized for its integrity, transparency, and dedication to creating a positive impact on people's lives.
9 analysts currently rate the All Cosmos Bio-Tech Holding stock: 0 recommend buying, 3 holding and 6 selling.
Converted at the current exchange rate, the All Cosmos Bio-Tech Holding share trades at 0.83 EUR (30.10 TWD).
The All Cosmos Bio-Tech Holding Corp is a Taiwan-based holding company that operates in various business sectors. The company has been in the market for over 30 years and has successfully diversified into diverse industries during this time. The All Cosmos Bio-Tech Holding Corp is divided into several subsidiaries that operate in the following business sectors: 1. Biotechnology Division: The company's Biotechnology Division specializes in offering innovative products and services in the field of biotechnological research and development. The company produces and distributes a wide range of biotechnology products such as enzymes, proteins, and antibodies. Additionally, the company also offers services in the research and development of biotechnology products. 2. Agriculture Division: The company's Agriculture Division is engaged in agriculture and specializes in the production of leafy vegetables and herbs. The company has its own cultivation areas and produces organic, fresh vegetables and herbs under strict quality assurance conditions. The products are sold directly to consumers or food production companies. 3. Real Estate Division: The company's Real Estate Division manages and develops real estate projects in Taiwan and other Asian countries. It develops and operates its own office and residential properties but also engages in partnerships with other real estate investors. 4. Service Division: The company's Service Division offers a wide range of services, including consulting, marketing, and outsourcing solutions to other companies. Additionally, the company is also engaged in the trade of industrial machinery and equipment. In the last few decades, the All Cosmos Bio-Tech Holding Corp has successfully diversified into various industries to strengthen its market position. The company focuses on strict quality control and continuous research and development to remain competitive. In addition to the aforementioned business sectors, the company also offers a wide range of products tailored to these different sectors. For example, the Biotechnology Division provides antibodies, enzymes, and proteins, while the Agriculture Division produces fresh vegetables and herbs. The company also continues to strive to explore new business sectors to expand its offerings and competencies. Overall, the All Cosmos Bio-Tech Holding Corp is a successful Taiwanese company operating in various industries. The company relies on quality control, innovation, and diversification to survive in a competitive market environment.
The revenue cannot currently be calculated for All Cosmos Bio-Tech Holding.
The profit cannot currently be calculated for All Cosmos Bio-Tech Holding.
The P/E ratio cannot be calculated for All Cosmos Bio-Tech Holding at the moment.
The P/S cannot be calculated for All Cosmos Bio-Tech Holding currently.
The Eulerpool Quality Score for All Cosmos Bio-Tech Holding is 2/10.
The ISIN of All Cosmos Bio-Tech Holding is KYG0232P1072. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of All Cosmos Bio-Tech Holding is 4148.TW. The ticker symbol is used to trade All Cosmos Bio-Tech Holding shares on the stock exchange.
All Cosmos Bio-Tech Holding stock
All Cosmos Bio-Tech Holding Peer Group
All Cosmos Bio-Tech Holding FIGI
All fundamentals and in-depth analysis of All Cosmos Bio-Tech Holding
Our stock analysis for All Cosmos Bio-Tech Holding stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of All Cosmos Bio-Tech Holding. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.